ABERG A K GUNNAR has a total of 18 patent applications. Its first patent ever was published in 1989. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are MA SHEN KAI RUEI CO LTD, BIOVAIL LAB INT SRL and CURA THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 9 | |
#2 | United States | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Aberg A K Gunnar | 18 |
#2 | Ciofalo Vincent B | 3 |
#3 | Ondetti Miguel A | 2 |
#4 | Johnson Keith | 2 |
#5 | Ferrer Patricia | 2 |
#6 | Ogletree Martin L | 2 |
#7 | Meier Viktor | 1 |
#8 | O'Keefe Eugene H | 1 |
#9 | Gogritchiani Eliso | 1 |
#10 | Friedhoff Lawrence | 1 |
Publication | Filing date | Title |
---|---|---|
US2014113936A1 | Medicinal treatment of dermal diseases in companion animals | |
WO2011068786A2 | Treating xerophthalmia with compounds increasing meibomian gland secretion | |
US2010130550A1 | Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen | |
US2009054338A1 | Synergisms between repartitioning and immunomodulating compounds | |
CA2550959A1 | Methods for relaxation of smooth muscle contractions using trospium | |
CA2550604A1 | Methods for treating smooth muscle disorders using trospium | |
CA2007896A1 | Method of treating hypertension using a thromboxane a2 receptor antagonist and new combinations | |
CA2006086A1 | Method of preventing or treating atherosclerosis using a thromboxane a receptor antagonist |